In a meta-analysis, topical Janus kinase (JAK) inhibitors demonstrated promising but non-significant results for vitiligo, with patients administered JAK inhibitors having a higher likelihood of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results